Find a Pharmacy
Vertice Login
Menu
close
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

FDA Orders Opioid Manufacturers to Update Prescribing Information for Long-Term Use

Labeling changes must address safety considerations including the limited use of extended-release formulations, safe discontinuation, and more.
Read More →
August 25, 2025

Oregon’s MLAC Discusses Access to Care

Two recent committee meetings addressed access to care, exclusive remedy, and more.
Read More →
August 25, 2025

California Shares Key Updates at CHWSC Meeting

Topics covered included recent MTUS updates, the pharmacy fee schedule update, UR and IMR updates, and more.
Read More →
August 18, 2025

Texas Requests Feedback for 2026 Research Agenda

Stakeholders can submit feedback on the research agenda by September 15th.
Read More →
August 18, 2025

Oklahoma Solicits Public Feedback on Medical Fee Schedule

Public comments will be accepted on the current fee schedule until September 7th.
Read More →
August 18, 2025

Michigan Proposes Cancer Presumption for Medical Examiners

The presumption would cover a wide variety of cancers for medical examiners with 60 months of active duty, or exposure to certain hazardous incidents.
Read More →
August 18, 2025

Colorado Meeting Reviews Workers’ Comp Reform Requirements

The DoWC discussed requirements from the recently enacted House Bill 1300, which mandates vast workers’ comp reforms.
Read More →
August 18, 2025

Alaska Finalizes 2026 Fee Schedule Recommendations

Recommended changes will be reviewed by the WCB and MSRC on August 22nd, with final adoption expected in October, and taking effect in 2026.
Read More →
August 18, 2025

WCRI Publishes New Study on High-Cost Back and Shoulder Injuries

Reviewing 194,000 claims, the report found that claims with degenerative comorbid conditions are 58% more likely to become a high-cost claim.
Read More →
August 11, 2025
1 … 32 33 34 35 36 … 63

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Wisconsin Announces Plan to Lower Prescription Drug Costs

State-led efforts to combat the drug price issue continue to emerge across the nation.
Read More

COVID-19 Mutations Impact Testing

False negatives may be reported due to genetic variations of the virus.
Read More

Worker Classification Debate Continues Across the Country

The Department of Labor issued a new rule while special interest groups push for regulatory change.
Read More

The Department of Justice Sues Walmart Over Role in Opioid Crisis

Alleged violations of the Controlled Substances Act could result in billions of dollars in penalties.
Read More

Top 10 Disruptors of 2020 for the Workers’ Comp Industry

Initial insights from Healthesystems’ annual industry survey.
Read More

FDA Authorizes Two COVID-19 Vaccines, At-Home Test, More Treatments

Vaccine candidates from Pfizer-BioNTech and Moderna received EUAs, as did the first at-home test that delivers results in 30 minutes, and two treatments for the virus.
Read More
1 … 32 33 34 35 36 … 53
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle